back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-03 14:53 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Options
70 - Acquisition or disposition (writing) of third party derivative
|
$8,250
+5,000 vol $1.65 each |
5,000 | |
| Filed 2026-06-03 14:51 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-03 14:51 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Options
70 - Acquisition or disposition (writing) of third party derivative
|
$8,250
+5,000 vol $1.65 each |
5,000 | |
| Filed 2026-06-03 13:36 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-03 12:32 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,573,870
+103,002 vol $15.28 each |
274,811 | |
| Filed 2026-06-03 12:30 Tx date 2026-06-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$751.66
+49 vol $15.34 each |
171,809 | |
| Filed 2026-06-03 12:30 Tx date 2026-06-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,624,492
+171,760 vol $15.28 each |
171,760 | |
| Filed 2026-06-03 12:28 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners IV, Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-03 12:27 Tx date 2026-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,573,885
+103,003 vol $15.28 each |
324,814 | |
| Filed 2026-06-03 12:26 Tx date 2026-06-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$767.00
+50 vol $15.34 each |
221,811 | |
| Filed 2026-06-03 12:24 Tx date 2026-06-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,624,508
+171,761 vol $15.28 each |
221,761 | |
| Filed 2026-06-03 12:23 Tx date 2026-05-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
97 - Other
|
+50,000 vol |
50,000 | |
| Filed 2026-06-03 12:21 Tx date 2026-05-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
97 - Other
|
-50,000 vol |
7,205,442 | |
| Filed 2026-06-03 12:17 Tx date 2026-05-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,021,661
+262,682 vol $15.31 each |
7,255,442 | |
| Filed 2026-06-03 12:13 Tx date 2026-05-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,289
+2,299 vol $15.35 each |
6,992,760 | |
| Filed 2026-03-04 14:06 Tx date 2026-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$818,574
+57,565 vol $14.22 each |
5,239,039 | |
| Filed 2026-03-04 14:05 Tx date 2026-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$514,188
+36,185 vol $14.21 each |
5,181,474 | |
| Filed 2026-03-04 14:05 Tx date 2026-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$374,199
+26,113 vol $14.33 each |
5,145,289 | |
| Filed 2026-03-04 14:04 Tx date 2026-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,190
+500 vol $14.38 each |
5,119,176 | |
| Filed 2026-03-04 14:04 Tx date 2026-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$947,974
+67,137 vol $14.12 each |
5,118,676 | |
| Filed 2026-03-04 14:03 Tx date 2026-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,303,125
+93,750 vol $13.90 each |
5,051,539 | |
| Filed 2026-03-04 14:02 Tx date 2026-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800,863
+126,643 vol $14.22 each |
6,990,461 | |
| Filed 2026-03-04 14:01 Tx date 2026-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,131,215
+79,607 vol $14.21 each |
6,863,818 | |
| Filed 2026-03-04 14:00 Tx date 2026-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$823,229
+57,448 vol $14.33 each |
6,784,211 | |
| Filed 2026-03-04 13:59 Tx date 2026-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,818
+1,100 vol $14.38 each |
6,726,763 | |
| Filed 2026-03-04 13:58 Tx date 2026-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,085,552
+147,702 vol $14.12 each |
6,725,663 | |
| Filed 2026-03-04 13:57 Tx date 2026-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,866,875
+206,250 vol $13.90 each |
6,577,961 | |
| Filed 2025-08-06 13:15 Tx date 2025-08-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,022,233
+87,520 vol $11.68 each |
4,957,789 | |
| Filed 2025-08-06 13:14 Tx date 2025-08-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$496,238
+43,760 vol $11.34 each |
4,870,269 | |
| Filed 2025-08-06 13:13 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,428,512
+437,600 vol $10.12 each |
4,826,509 | |
| Filed 2025-08-06 13:12 Tx date 2025-08-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,313,766
+112,480 vol $11.68 each |
6,371,711 | |
| Filed 2025-08-06 13:11 Tx date 2025-08-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$637,761
+56,240 vol $11.34 each |
6,259,231 | |
| Filed 2025-08-06 12:33 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,691,488
+562,400 vol $10.12 each |
6,202,991 | |
| Filed 2025-08-06 12:32 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
97 - Other
|
-500,000 vol |
0 | |
| Filed 2025-08-06 12:31 Tx date 2025-08-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
97 - Other
|
+500,000 vol |
5,640,591 | |
| Filed 2025-03-07 15:53 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,227,104
+281,200 vol $7.92 each |
5,140,591 | |
| Filed 2025-03-07 15:52 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$666,056
+83,257 vol $8.00 each |
4,859,391 | |
| Filed 2025-03-07 15:51 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$454,981
+56,240 vol $8.09 each |
4,776,134 | |
| Filed 2025-03-07 15:51 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,587,502
+197,943 vol $8.02 each |
4,719,894 | |
| Filed 2025-03-07 15:50 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$451,460
+56,645 vol $7.97 each |
4,521,951 | |
| Filed 2025-03-07 15:49 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,762,756
+224,555 vol $7.85 each |
4,465,306 | |
| Filed 2025-03-07 15:48 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,732,896
+218,800 vol $7.92 each |
4,388,909 | |
| Filed 2025-03-07 15:48 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$518,248
+64,781 vol $8.00 each |
4,170,109 | |
| Filed 2025-03-07 15:47 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$354,018
+43,760 vol $8.09 each |
4,105,328 | |
| Filed 2025-03-07 15:46 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,235,232
+154,019 vol $8.02 each |
4,061,568 | |
| Filed 2025-03-07 15:46 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$351,277
+44,075 vol $7.97 each |
3,907,549 | |
| Filed 2025-03-07 15:45 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,371,591
+174,725 vol $7.85 each |
3,863,474 | |
| Filed 2025-03-07 15:43 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
97 - Other
|
+3,688,749 vol |
3,688,749 | |
| Filed 2025-03-07 15:42 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners International, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-07 15:41 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
97 - Other
|
-3,688,749 vol |
4,240,751 | |
| Filed 2024-12-10 16:57 Tx date 2024-12-09 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,545,000
+500,000 vol $9.09 each |
7,929,500 | |
| Filed 2024-12-10 16:55 Tx date 2024-12-06 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,604,000
+400,000 vol $9.01 each |
7,429,500 | |
| Filed 2024-12-10 16:55 Tx date 2024-12-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,673,000
+300,000 vol $8.91 each |
7,029,500 | |
| Filed 2024-10-23 12:07 Tx date 2024-10-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Options
52 - Expiration of options
|
$-180,000
-30,000 vol $6.00 each |
0 | |
| Filed 2024-09-22 21:49 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,000 | ||
| Filed 2024-09-22 21:45 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners III, Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2024-09-22 21:44 Tx date 2024-09-12 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Tang, Kevin
4 - Director of Issuer
Holder: Tang Capital Partners, LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,729,500 |